Company Overview
- Headquarters
- 9360 Towne Centre Drive, San Diego CA
- Website
- biosplice.com
- Employees
- 63
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$50B
Who is Biosplice Therapeutics
Biosplice Therapeutics is a privately held company based in San Diego, California. With 63 employees, the company focuses on developing innovative small-molecule therapeutics. Biosplice specializes in pioneering science related to alternative pre-mRNA splicing, a crucial biological mechanism that regulates protein diversification within cells. Their research centers on CLK/DYRK kinases, which play a key role in the therapeutic regulation of alternative splicing. Biosplice's drugs target tissue-specific mRNA splice sites, aiming to influence cellular function. Their clinical pipeline includes lorecivivint, currently in Phase 3 trials for osteoarthritis, and cirtuvivint, targeting various cancers. Biosplice is also exploring treatments for Alzheimer's disease and other degenerative conditions. For more information, visit Biosplice Therapeutics' website at www.biosplice.com.
Company Leadership
Biosplice Therapeutics Industry Tags
Companies Similar to Biosplice Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Biosplice Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | Cambridge, MA | |||
| 50M | 59 | Foster City, CA | ||
| 50M | 74 | San Diego, CA | ||
| 50M | 181 | New Haven, CT | 2017 | |
| 50M | 58 | Carlsbad, CA |